Podcasts about mscs

In the biotech industry, advancing cell-based therapies is not just about innovation. It's about solving real gaps where conventional treatments fall short, especially against complex, aggressive tumors.In this episode of the Smart Biotech Scientist Podcast, host David Brühlmann welcomes Jun Yung Woo, Co-Founder of AGEM Bio, who offers an in-depth look at the science and strategy behind engineered mesenchymal stem cells (MSCs), with a focus on why glioblastoma is the right proving ground for the platform.Topics discussed:Why glioblastoma is the right Phase I indication: infiltrative growth, immunosuppression, and STING pathway deficiencies that make GBM uniquely suited to the platform (02:43)The surgical workflow: intracavity MSC delivery during tumor resection, oral 5-FC administration, and how engineered cells act as local bioreactors in the resection cavity (04:05)Mechanisms by which engineered MSCs target heterogeneous and invasive tumors through shared vulnerabilities rather than antigen recognition (05:58)Overcoming immune rejection with allogeneic therapies and the unique immunological profile of MSCs (07:32)Manufacturing and scale-up: addressing donor variability, GMP production, and building a reproducible process (09:16)Why GMP manufacturing should be designed in from the earliest stages of research (10:50)Beyond glioblastoma: expanding the platform to other solid tumors, regenerative medicine, and chronic inflammatory disease (11:27)Strategies for international trial expansion and partnerships beyond Singapore (12:41)Reframing MSCs from stem cell therapy to programmable delivery platform: the MSC 2.0 thesis (14:10)Smart insight: The shift Jun Yung articulates is from treating stem cells as the therapy to treating them as programmable therapeutic vehicles. Once you can reliably engineer, manufacture, and preserve their function, the limitation is no longer what the cell naturally does. It becomes what biology you can encode into it. Glioblastoma is the proving ground, and the platform's reach extends to liver cancers, sarcomas, peritoneal malignancies, and chronic inflammatory disease.These episodes expand on the same themes of MSC biology, cell engineering, and the challenges of scaling consistent, functional cell therapies:Episodes 179 - 180 : How Mesenchymal Stromal Cells Are Transforming Care for Diabetes and Autoimmune Diseases with Lindsay DaviesEpisodes 253 - 254: How to Source, Manufacture, and Scale the Earliest Stem Cells for Allogeneic Cell Therapy Without Ethical Barriers with Yuta LeeEpisodes 125 - 126: How to Enhance Cell Engineering Using Mechanical Intracellular Delivery with Armon ShareiEpisodes 129 - 130: Revolutionizing Cell Therapy Manufacturing: Reducing Costs to Reach More Patients with Jason FosterConnect with Jun Yung Woo:LinkedIn: www.linkedin.com/in/junyungwooAGEM Bio website: www.agem.bioEmail: yung@agem.bioSupport the show

What if the answer to solid tumor therapy isn't about making immune cells smarter—but about rethinking what a therapeutic cell can do For years, mesenchymal stem cells (MSCs) have turned heads for their ability to home in on damaged tissue, yet their clinical utility has lagged behind the hype. What would it take to transform MSCs from passive healers into precision vehicles for next-generation cancer treatment?This week, David Brühlmann sits down with Jun Yung Woo, Co-Founder of AGEM Bio, who's devoted nearly two decades to decoding and reimagining the potential of MSCs. From engineering stress-resilient cells to pioneering dual-payload therapeutic platforms, Jun Yung Woo bridges fundamental biology and real-world clinical translation.Topics discussed:The case for understanding cell biology before focusing on process scale-up in bioprocessing (02:38)Jun Yung Woo's personal and scientific journey toward developing engineered MSC therapeutics (04:36)How MSCs sense their environment and exert therapeutic effects via secreted factors, rather than tissue replacement (08:28)Key differences between MSC therapies and immune cell therapies like CAR T cells (10:35)Overview of non-viral engineering platforms, and the importance of intracellular trafficking for modifying MSCs (12:23)Design of AGEM Bio's dual-payload MSC product (cytosine deaminase and interferon beta) to induce highly localized tumor stress and immune activation (14:10)Strategies for controlling MSC targeting and minimizing off-target effects, including the use of prodrug activation and localized cell delivery (17:23)Study results from treating companion animals with engineered MSCs, and observations of tumor regression and possible signs of immune memory (20:29)Open questions about the durability of antitumor responses and future directions for clinical research (22:34)Smart insight: Jun Yung Woo challenges the rush toward bioprocess scale-up, arguing that a deeper understanding of cellular biology should come before manufacturing cells at scale. This episode explores how scaling the wrong biology can derail entire therapeutic platforms—and why aligning process development with cellular function may be critical for clinical success.These episodes expand on the same themes of MSC biology, cell engineering, and the challenges of scaling consistent, functional cell therapies:Episodes 179 - 180 : How Mesenchymal Stromal Cells Are Transforming Care for Diabetes and Autoimmune Diseases with Lindsay DaviesEpisodes 253 - 254: How to Source, Manufacture, and Scale the Earliest Stem Cells for Allogeneic Cell Therapy Without Ethical Barriers with Yuta LeeEpisodes 125 - 126: How to Enhance Cell Engineering Using Mechanical Intracellular Delivery with Armon ShareiEpisodes 129 - 130: Revolutionizing Cell Therapy Manufacturing: Reducing Costs to Reach More Patients with Jason FosterConnect with Jun Yung Woo:LinkedIn: www.linkedin.com/in/junyungwooAGEM Bio website: www.agem.bioEmail: yung@agem.bioSupport the show

According to State Comptroller Jason Mumpower, the MSCS audit details over $119 million in fraud, waste, and abuse. “The findings in this report represent some of the worst organizational management we have ever seen anywhere in government." Will there be any actual repercussions, or will this be swept under the rug? Also on the show: Iran (SHOCKINGLY) broke their ceasefire and people are calling for total annihilation, John Rose is campaigning for Governor like his life depends on it, and a Chattanooga train conductor got fired for what some say are xenophobic statements.See omnystudio.com/listener for privacy information.

My guests include State Senator Raumesh Akbari. With the redistricting issue at the forefront of the upcoming elections, I wanted to catch up with her to have her share why this is no time to be complacent. Also, her feelings about the MSCS oversight committee and what might this look like moving forward. Next, the County Commission just approved the new budget but not without a property tax increase. Charlie Caswell joins me to discuss what many have said was a challenging session and the prospects of working with a new group of members. Lastly, we are all becoming familiar with the new world of technology led by AI. CodeCrew is helping to mentor underrepresented youth and adults to be the next tech innovators through computer science. CEO Meka Egwuekwe joins to tell us how. That and more on air and online, 6pm on 91.7 FM WYXR. Also, the WYXR app, Tunein, Facebook Live and wherever you get your podcasts.It's time to talk!

The world's most famous German (not the World War 2 one), Freddie, has deactivated his account after Germany was eliminated from the World Cup and there are some conspiracies and facts revealed about his tenure in the United States. Was this all a misunderstanding, or was he misleading us on purpose the whole time? Also on the show: Ben Crump reveals the independent autopsy results of one-year-old Kohen Wiley, a couple climbed the Empire State Building undetected, a MSCS takeover restraining order halting the oversight board, and Stephen A. Smith is anti-white NBA players apparently. See omnystudio.com/listener for privacy information.

In this episode of the Health Optimization Medicine Podcast, the HOMeHOPe faculty, Dr. Scott Sherr, Dr. Ted Achacoso, Dr. Jup Kuipers, and Dr. Allen Bookatz reunite in person in Washington, D.C.. Moving away from traditional classifications of illness, the team breaks down a powerful paradigm shift: chronic disease and aging are not separate processes—chronic disease is aging. Drawing from the pioneering frameworks of biogerontologist Aubrey de Grey and the SENS Research Foundation, they discuss how flawed metabolism inherently accumulates structural damage long before a clinical diagnosis ever appears. Join us as we delve into: •The Metabolism Flaw: How the very process keeping us alive produces reactive oxygen species and damage that eventually leads to tissue breakdown and pathology. •Reclassifying Disease: Moving past the old congenital vs. infectious vs. chronic model to target metabolism directly. •The $30,000 Stem Cell Mistake: Why dropping thousands on mesenchymal stem cells (MSCs) or exosomes is a waste of money if your body is trapped in a cellular defense posture. •The Cell Danger Response (CDR): Understanding Robert Naviaux's work on how ancient defense mechanisms shut down growth and repair under stress. •Morbidity Compression: Shifting your biology back to your optimal 21-to-30-year-old baseline to maximize healthspan and ensure you live vibrant before a rapid, peaceful end. This episode is for you if: •You want to understand why biohacking shortcuts like stem cells require metabolic priming to actually work. •You are tired of "normal" lab ranges meant for a sick population and want true, age-optimized biomarkers. •You want to stop guessing what vitamins or antioxidants your body needs and start measuring your exact metabolomic fingerprint. You can also find this episode on… YouTube: https://youtu.be/DygsezbmZxM  Find more from Health Optimization Medicine and Practice (HOMeHOPe): Website: https://homehope.org/ Instagram: https://www.instagram.com/homehopeorg/ HOMeHOPe Conference 2026: https://homehope.org/homehope-conference-2026 Use PODCAST10 to get 10% OFF your purchase of the Clinical Metabolomics Module at https://homehope.org/products/clinical-metabolomics Find more from Troscriptions: Website: https://troscriptions.com/ Instagram: https://www.instagram.com/troscriptions/ Use POD10 to get 10% OFF your Troscriptions purchase at https://troscriptions.com/collections/our-products 

Former Shelby County Commissionor Terry Roland told Ditch & Tim during Memphis Morning News that the county is broke and a forensic audit needs to be performed on Mayor Lee Harris administration. Terry also says that the state takeover of Memphis Shelby County Schools will be overturned after a federal court looks at it. He explains that one body is appointed and the other is elected. Support the show: https://www.newstalk989.com/personalities/memphis-morning-news/See omnystudio.com/listener for privacy information.

Several politicians were in hot water after attending George Floyd memorial events and paying homage on social media instead of Memorial Day events like Tim Walz and Jacob Frey. Then, on The Breakfast Club, Kevin Hart was asked about the George Floyd jokes made during his Netflix roast and his answer might surprise you! Also on the show: several clips went viral of reporters reacting in real-time to the shooting at the White House, almost all of the members of the MSCS oversight board have been selected, Producer Rivera reviews Mandalorian & Baby Yoda, and we play two rounds of Impossible Spelling Bee!See omnystudio.com/listener for privacy information.

Most psychiatric treatments for autism don't address what's actually happening underneath the diagnosis. They subdue. They don't repair.In this episode, I sit down with Karen Thomas of Naturally Recovering Autism to break down what stem cell therapy can actually do for children on the spectrum.Children with autism show impaired central nervous system circulation, active neuroinflammation on brain autopsy, and higher rates of autoimmune patterns in their families. Mesenchymal stem cells, MSCs, address all three at once. They stimulate angiogenesis to restore blood flow and oxygen to the brain, suppress pathological immune responses, reduce neuroinflammation, and secrete factors that activate the body's own local stem cells. I share a clinical case of a seven-year-old who went from diaper-bound and non-verbal to verbal, continent, and climbing stairs after a single IV treatment with birth-tissue-derived cells. We also get into why not all MSCs are created equal, why 200 million expanded cells overseas often underperform 20 million original cells, what the FDA's Section 361 actually means, and how I sourced and built the cell product used in my clinic through Chara Biologics.We close on why no stem cell protocol works in isolation. Diet, detox, nutrient status, and exercise are part of the protocol, not optional add-ons.If your child is on the spectrum, or you work with families who are, this is the mechanism and sourcing breakdown most parents never get.Joy talks about:00:00 What stem cell therapy actually is05:37 The three mechanisms underlying autism08:46 How MSCs restore oxygen to the brain10:54 From non-verbal and diaper-bound to talking and walking stairs16:25 Why your own bone marrow cells may not be the answer19:58 Are all MSCs created equal21:55 FDA Section 361 and what's legal in the US23:34 Why 200 million expanded cells underperform 20 million original27:39 Inside the sourcing and 89-question donor screening43:42 Why diet and detox decide whether stem cells workAdditional Resources✨ Listen to Naturally Recovering Autism with Karen Thomas: https://naturallyrecoveringautism.com/ ✨ Karen's free four-stage webinar for parents: https://naturallyrecoveringautism.com/freeworkshop Visit My Clinic: 

Can aging be fundamentally slowed or even reversed—not by science fiction, but by harnessing the unassuming power of super-early stem cells?In Part 1, Yuta Lee, Founder and CEO of Accelerated Bio, walked through the biology, ethical sourcing, and manufacturing profile of human trophoblast stem cells. In Part 2, the conversation shifts to the larger ambition: using those cells not just to treat disease, but to slow, stop, or reverse biological aging itself. The evidence starts with a striking finding from the National Institute on Aging, and it builds from there.Topics discussed:The science and ethics of sourcing stem cells from ectopic pregnancies (03:02)Differences in differentiation potential between very early-stage cells and traditional MSCs or iPSCs (05:09)The origins of the research focus, driven by NIH/NIA inquiry and lessons from Stanford parabiosis studies (07:27)Explanation of senescent cells, inflammation, and disease connections (08:51)Potential therapeutic scope, from neurodegeneration to autoimmune diseases, and systemic anti-inflammatory applications (09:26)Vision for aging prevention—possibility of maintaining young biological age through regular secretome therapy (10:21)Challenges and global differences in regulation, access, and clinical adoption (12:05)The realistic limits and potential for reversing versus preventing age-related damage (13:20)The future landscape of cell and gene therapy in medicine (14:20)Why more investment is needed in longevity science and therapeutics (16:25)Practical takeaways for listeners about improving healthspan and longevity today (18:07)Smart insight:Prevention is becoming the new frontier of medicine, shifting from treating disease to preserving long-term biological function. Yuta Lee highlights a future where proactive longevity strategies, from lifestyle choices to emerging biotech, could keep us healthier for longer and push toward “escape velocity” against aging.If you're interested in how we turn living biology into scalable, reliable, off-the-shelf therapies without losing control of the system, explore these episodes:Episodes 105 - 106: From Proteins to Cell Therapy: Why ATMPs Aren't Just Complex Biologics with Oliver KraemerEpisodes 147 - 148: Lab-Grown Blood: How Stem Cells Transform Transfusions with Ari GargirEpisodes 179 - 180: How Mesenchymal Stromal Cells Are Transforming Care for Diabetes and Autoimmune Diseases with Lindsay DaviesEpisodes 211 - 212: When the Innovator Becomes the Patient: Manufacturing Reality vs. Patient Urgency with Jesús ZurdoConnect with Yuta Lee:LinkedIn: www.linkedin.com/in/yuta10Accelerated Bio website: www.acceleratedbio.comNext:If you enjoyed this episode, please leave a review on Apple Podcasts or your favorite podcast platform. By doing so, we can empower more scientists like you. Stay tuned for more inspiring biotech insights in our next episode.Support the show

Acute respiratory distress syndrome (ARDS) induced by COVID-19 was a leading cause of severe illness and death during the pandemic, driven by an intense innate immune response, hyperinflammation, and a decrease in lymphocytes. Mesenchymal stromal cells (MSCs) represent a potential therapeutic option for ARDS due to their ability to modulate the immune system and inflammation. Our guests report results from a Health Canada–regulated Phase I and Phase II trials evaluating freshly cultured umbilical cord–derived MSCs in patients with COVID-19-related ARDS, including assessments of safety, maximum feasible tolerated dose, and preliminary efficacy. Their work explores a therapeutic strategy to improve ARDS outcomes using MSCs, which will be important for optimizing and targeting future cellular therapies.GuestDuncan Stewart, MD, Ottawa Hospital Research Institute and University of Ottawa, CanadaElmira Safaie Qamsari, Ottawa Hospital Research Institute, CanadaHostJanet Rossant, Editor-in-Chief, Stem Cell Reports and The Gairdner FoundationSupporting DocumentsPaper link: Cellular immunotherapy for COVID-19-induced acute respiratory distress syndrome: Results of the CIRCA-19 phase 1 safety and phase 2 randomized controlled trials About Stem Cell ReportsStem Cell Reports is the open access, peer-reviewed journal of the International Society for Stem Cell Research (ISSCR) for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians. X: @StemCellReportsAbout ISSCRAcross more than 80 countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to advancing stem cell research and its translation to medicine.ISSCR StaffKeith Alm, Shuangshuang Du, Kym Kilbourne, Megan Koch, Jack Mosher, and Hunter Reed

What if the key to scalable, off-the-shelf cell therapy was hiding in tissue that surgeons discard every day?Yuta Lee, Founder and CEO of Accelerated Bio, has spent two decades building a cell therapy platform on exactly that insight. Human trophoblast stem cells, sourced from ectopic pregnancy tissue that is otherwise discarded, sit at a unique biological intersection: earlier than MSCs, free from the ethical barriers of embryonic stem cells, expandable to 85 population doublings, and naturally equipped with HLA-G immune modulation that opens the door to allogeneic, off-the-shelf therapy at scale.Topics discussedCommon misconceptions and challenges in bioprocess development for biological therapeutics (02:45)The origin story behind Yuta Lee's interest in stem cells, including his father's surgical discovery (04:15)A look at the intellectual property strategy that protected and enabled Yuta Lee's company to develop its platform (07:26)A clear explanation of different stem cell types (embryonic, trophoblast, mesenchymal, adult, and induced pluripotent) and their sources (09:37)Ethical and regulatory issues involved in sourcing stem cells, and how trophoblast cells offer a unique alternative (10:59)Discussion of stem cell differentiation, population doubling, and scalability for manufacturing purposes (17:03)Importance of immune privilege and HLA-G expression in pre-placental cells for off-the-shelf therapies (20:20)Shifts in the industry from autologous to allogeneic therapies, and the role trophoblast cells may play in future treatments (22:00)In Part 2, Yuta Lee goes into the science of biological aging, the senescent cell secretome findings from the National Institute on Aging, and what a prevention-first therapeutic approach to healthspan extension could look like in practice.Smart insight:The scalability ceiling of MSCs is not just a manufacturing inconvenience, it is a strategic constraint. At 25 to 30 population doublings from birth-derived donors, every new donor batch requires revalidation as a distinct biological starting material. Trophoblast stem cells at 85 doublings from a single donor change that equation fundamentally, making true allogeneic scale not just biologically possible but manufacturable.If you're interested in how we turn living biology into scalable, reliable, off-the-shelf therapies without losing control of the system, explore these episodes:Episodes 105 - 106: From Proteins to Cell Therapy: Why ATMPs Aren't Just Complex Biologics with Oliver KraemerEpisodes 147 - 148: Lab-Grown Blood: How Stem Cells Transform Transfusions with Ari GargirEpisodes 179 - 180: How Mesenchymal Stromal Cells Are Transforming Care for Diabetes and Autoimmune Diseases with Lindsay DaviesEpisodes 211 - 212: When the Innovator Becomes the Patient: Manufacturing Reality vs. Patient Urgency with Jesús ZurdoConnect with Yuta Lee:LinkedIn: www.linkedin.com/in/yuta10Accelerated Bio website: www.acceleratedbio.comNext:If you enjoyed this episode, please leave a review on Apple Podcasts or your favorite podcast platform. By doing so, we can empower more scientists like you. Stay tuned for more inspiring biotech insights in our next episode.Support the show

In this episode of Denatured, you'll be hearing from Miguel Forte, president of the International Society for Cell and Gene Therapy (ISCT), and John Ellis, co-founder & CEO of Trenchant Bios, speaking live from the ISCT annual meeting. We dive into mesenchymal stem cells and induced pluripotent stem cells, exploring the science behind them, the manufacturing challenges, and the potential for scalable, engineered next-generation therapies.HostJennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsJon Ellis, Co-founder & CEO, Trenchant BioMiguel Forte, President, International Society for Cell & Gene TherapyDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

It's the day of lightsabers, x-wings, Jar-Jar, and jawas! Happy Star Wars Day, we celebrate by giving you our rankings of all-time Star Wars movies, moments, and putting Producer Rivera to the test as we play Star Wars trivia. Does Rivera know Star Wars ball, or is he a fake nerd like the rest of 'em? Also on the show: Joy Reid is starting the "JD Vance is worse than Trump" campaign already, former NYC Mayor Rudy Giuliani is still in critical condition battling pneumonia, and more updates on Shelby County Mayor Lee Harris fighting MSCS state oversight!See omnystudio.com/listener for privacy information.

Episode Notes My guests include TN State Senator Raumesh Akbari. After an uneventful legislative session that concluded with the unexpected passing of G.A. Hardaway, we were even more shocked with a Supreme Court ruling that could change our city forever. A redistricting effort by the state that will split the 9th congressional district 3-ways turning it republican. We discuss. Next, the legislative body also voted to Takeover the daily function of MSCS by appointing a nine member management group to oversee the daily operations of the elected members. Michelle McKissack joins me to discuss this unprecedented move. Finally, we have seen an escalation in youth violence which made me ask how connected they are to the church and vice versa. Rev. William Thomas, (Pastor Bill) of Fullview MB Church is their Youth pastor and shares his thoughts. That and more on air and online Monday, 6 pm on 91.7 FM WYXR. Also, the WYXR app, Tunein, Facebook Live, YouTube and wherever you get your podcasts. It's time to talk!

Full Show Notes: https://bengreenfieldlife.com/purita In this episode with Dr. Joseph Purita, Chief Medical Officer of PUR-FORM and a pioneer in regenerative medicine with over 40 years in the field, you'll explore the cutting-edge therapies, protocols, and emerging science reshaping what is possible in human health and longevity. Dr. Purita breaks down how EBO2 works, why photobiomodulation across six distinct wavelengths, each targeting a different cellular mechanism from mitochondrial energy production to viral inactivation, does far more than most people realize for healing and cellular regeneration, and how therapies like intermittent hypoxia, hyperbaric oxygen, and photoactivated NAD IVs can be stacked. You'll also get a deep dive into Muse cells, what makes them fundamentally different from regular MSCs, how they home in on damaged tissue like a magnet using S1P signaling, and why Dr. Purita believes they will be as transformative as MSCs were 20 years ago. You'll hear about the underrated IV therapies Dr. Purita uses at PUR-FORM, from photoactivated methylene blue and curcumin to intravenous spermidine and EGCG, the peptide stack he relies on, why nitric oxide support is central to his stem cell protocols, and what he has his eye on next including hydrogen therapy, the Klotho protein, and the emerging role of gene therapy in longevity medicine. Dr. Joseph Purita is a board-certified orthopedic surgeon who has been at the forefront of advancing stem cell and biologic therapies. He is also a sought-after global speaker in the regenerative medicine industry, most recently educating his peers on the science and clinical potential of Muse cells. Episode Sponsors Hiya: Give your kids the full-body nourishment they need to grow into healthy adults. I’ve secured a special deal with Hiya on their best-selling children's vitamin—get 50% off your first order today! To claim this deal, you must go to hiyahealth.com/BEN (it is not available on their regular website). Organifi Shilajit Gummies: Harness the ancient power of pure Himalayan Shilajit anytime you want with these convenient and tasty gummies. Get them now for 20% off at organifi.com/Ben. TruDiagnostic: TruDiagnostic is an advanced at-home health test that uses epigenetic analysis to measure over a million biomarkers, giving you personalized, data-driven insights into your aging, energy, and overall health so you can stop guessing and start optimizing with a clear plan. Visit TruDiagnostic.com and use code BEN20 for 20% off. Formula IQ: Recuperate IQ by Formula IQ is a comprehensive copper supplement designed to support mitochondrial energy, iron balance, and metabolic health by pairing bioavailable copper with essential cofactors your body needs for proper utilization, which is especially crucial if you've been under chronic stress or supplementing with high-dose zinc. Try it at formulaiq.com and use code BEN for 10% off. BON CHARGE: BON CHARGE is a holistic wellness brand with a wide range of products that naturally address the issues of modern life. Their products can help you sleep better, perform better, recover faster, balance hormones, reduce inflammation, and so much more. Go to boncharge.com/GREENFIELD and use coupon code GREENFIELD to save 15%.See omnystudio.com/listener for privacy information.

Former FBI Director James Comey has been charged by a federal grand jury for a controversial Instagram post from a year ago that President Donald Trump and officials of his administration felt constituted as threat to the president. Is Trump justified for this, or is this an over-exaggeration? Also on the show: Jake rants about the OTHER Mayor Lee Harris regarding his lawsuit on behalf of MSCS, Jimmy Kimmel explains his joke about Melania Trump looking like an expectant widow, and we play three rounds of Impossible Trivia Tuesday!See omnystudio.com/listener for privacy information.

For the third time in three years, Trump has become a target. We have a manifesto and clear motive, and still there are conspiracies that it was staged. How was the attempted assassin able to get this far? We break down all the details of the night and the insane reactions. Also on the show: JB Smiley stole Doug McGowan's tagline, people are calling for Jimmy Kimmel to be fired (again)), Rep. Ilhan Omar believes there was eleven World Wars, and County Mayor Lee Harris plans to sue the state of TN for MSCS oversight. See omnystudio.com/listener for privacy information.

"We NEED state intervention. I am an advocate." Strong words by former Memphis mayor Willie Herenton, who revealed his position on Brent Taylor's strong (and successful) push for an oversight board of MSCS. Democrats are calling oversight racist, and that Herenton is basically out of touch. Also on the show: Famous comedian Henry Cho, "The Korean Tennessean", joined the show to talk about the sacrifices he made on his comedy journey and to chop it up with Jake. Rivera also gives his full review of the Michael movie, and we reveal the weirdest TN town names. See omnystudio.com/listener for privacy information.

A bill for the state to establish an oversight board for Memphis Shelby County Schools was APPROVED by the Tennessee State Senate and House. The vote in the House was 73-19 and the State Senate result was 27-6. The governor’s desk will soon receive the bill, and Democrats are saying it's all racist. Shocked? Also on the show: Memphians are upset at NBA Commissioner Adam Silver for wanting the Grizzlies to play some games in Nashville, tiny earthquake tremors were (allegedly) felt in the Mid-South, and syndicated columnist Ron Hart joins the show to talk Iran. See omnystudio.com/listener for privacy information.

Are the roots of Earth Day communist? We break it down. Memphis is going through it with the news of 3 remains of children found in Hickory Hill, the bomb threat at the Bass Pro in the Pyramid, and the state takeover of MSCS getting approved by the TN House. So...happy Earth Day...? Also on the show: Adam Silver says the Grizzlies will stay in Memphis but play some in Nashville, we play the Wile E. Coyote v. ACME trailer, Alex Jones made a valid prediction about the Southern Poverty Law Center, and we give you today's Wheel of Weird story. See omnystudio.com/listener for privacy information.

Arctic fish survive in waters that would freeze most life solid. Not because they tolerate ice, but because their biology prevents crystals from forming in the first place. That same principle, translated into synthetic peptide chemistry, is now showing performance data that DMSO cannot match. Part 2 is where the science becomes practical.Steve Oh spent 22 years at Singapore's A*STAR accumulating 43 patents across stem cell bioprocessing, microcarrier technologies, and serum-free media. He now advises XTherma, where he has been stress-testing their DMSO-free cryopreservation solution across T cells, MSCs, organoids, and beyond. In Part 2, he brings the data.Key topics discussed:How antifreeze protein-inspired peptide chemistry reduces ice crystal size and protects cells during freezing and thawing (00:23)T cell and MSC performance data comparing XT Thrive to DMSO and CryoStor CS10, including a 2.5-fold increase in cell yield on microcarriers post-thaw (02:23-05:00)Why ice crystal formation causes more damage during thawing than freezing, and how XT Thrive addresses this (05:32)Elimination of the post-thaw wash step and what that means for contamination risk and manufacturing simplicity (07:00)Hold time extended to 24 hours and storage performance across 4°C, -80°C, and -196°C (08:01)Applicability beyond single cells: organoids, islets, and potential implications for organ preservation (09:50)How to transition from DMSO to XT Thrive: GMP grade, Drug Master File, same concentration, no protocol overhaul required (10:49)Broader cell therapy challenges: differentiation time, cell population consistency, and cost of goods (12:03)Smart insight:The transition away from DMSO is more accessible than most scientists assume. XT Thrive is GMP-grade, carries a Drug Master File, and is used at the same 5-10% concentration as DMSO, making it a plug-and-play substitution for most cell types. The manufacturing implications go further: no wash step, extended hold times, and storage stability across all standard temperature ranges simplify both production workflows and cold-chain logistics to remote treatment sites.If you're interested in this topic, check out these episodes, where we explore how Minnesota's frozen forests inspired a new wave of biotech innovation, transforming how life-saving cells are frozen, stored, and shipped.Episodes 161 - 162: How to Achieve 85%+ Cell Recovery Without DMSO's Toxic Side Effects with Jeffrey AllenThis is Steve's second appearance on the podcast. You can also catch his earlier conversation with David, where they explored the challenges and opportunities of cell and gene therapy.Episodes 11 - 12: From Lab to Patient: Steve Oh's Guide to Mastering Cell Therapy Process Development.Connect with Steve Oh:Email: skwohso@gmail.comLinkedIn: www.linkedin.com/in/steve-oh-4946261/Support the show

Already a TOP 3 best clip of the year so far. Overlooking the American people on a White House perch sits President Trump and the Easter Bunny, as Trump rambles about eggs, fake news, and Easter decorations. Then he spends time with kids during the egg hunt telling them about Biden's autopen and how he's the best. We break it all down. Also on the show: LeBron James DOUBLES DOWN on his hatred for Memphis, Artemis II breaks Apollo 13's record for the furthest distance humans have travelled from Earth, and MSCS released a website to give updates around problems found in an initial forensic audit of the district.See omnystudio.com/listener for privacy information.

Episode Notes My guests include newly appointed 9th District County Commissioner Matthew Szalaj and he joins me for a chat since taking the position. He recently had a meet and greet in front of a packed house and shares what drove his decision, gaining community trust, his priorities and what he wants to accomplish in his short tenure. Last week, the State legislature held a press conference to announce the findings of a long awaited financial audit to address various issues involving possible waste, abuse and fraud within MSCS. While only 25 percent complete, it shows what was found is to the tune of over $1.7 and $1.1 million dollars in policy issues and violations. State Representative Karen Camper, Democratic House Caucus Leader joins me to discuss. Lastly, the nationwide No Kings protest involved millions of people including a rally in Memphis. Jessica Miller of Indivisible Memphis and David Rahaim were participants, and he was one of three arrested. They share their experience. That and more Monday nite, 6pm on 91.7 FM WYXR. Also, the WYXR app, Tunein, Facebook Live, YouTube and wherever you get your podcasts! It's time to talk.

Basics of Research: Data Interpretation with Proshad Efune, MD, MSCS

Chuck Norris didn’t kick the bucket, he roundhouse kicked the bucket’s ass. Legendary gets tossed around but the passing of Chuck Norris truly reminded us what a legend he really was. We celebrate his life with reactions across social media, some Chuck Norris facts, and our memories of him. Also on the show: WVNN's Dale Jackson joined the show to talk about Chuck's legacy and political headlines, Dr. Marie Feagins filed a second lawsuit against MSCS for gender discrimination, and it's March Madness Not-So Spectacular Part 2. See omnystudio.com/listener for privacy information.

Not only is Brent Taylor pushing for legislation to create an appointed state oversight board for local schools, parents want it too! In recent years, trust in the school district has been low, especially following the controversial dismissal of Dr. Marie Feagins, and parents have had enough! Also on the show: some women want female Uber drivers, Gene Simmons tells celebrities to "shut the f up" about politics, AI is being used to locate the attempted MPD cop killer, and we play two rounds of Impossible Trivia Tuesday. See omnystudio.com/listener for privacy information.

Memphis-Shelby County School leaders vehemently opposed a potential state takeover of the district and presented a new plan to transform local schools. They REALLY don't like the idea of Sen. Brent Taylor's developing legislation to establish an appointed state oversight board for local schools. Also on the show: gay maps and racist bridges, WVNN's Dale Jackson stops by to talk about the latest political headlines, Biden claims to be the smartest in the room at Rev. Jesse Jackson's memorial, and today's Maxterpiece Theater. See omnystudio.com/listener for privacy information.

Multiple Sclerosis (MS) remains the leading cause of non-traumatic disability in adults aged 18–65. Because of its prevalence and the vital role of therapy in management, it is a clinical area we return to often at OT Potential.We previously explored this topic through the inspiring lens of Dr. Sarah Adam, OTD, OTR/L—a professor and Paralympic medalist living with MS. In this upcoming one-hour course, we continue the conversation by diving into the latest evidence-based research through the lens of an outpatient neurological specialist.Joining us is Makeda N. Jackson, OTD, OTR/L, MSCS, a Multiple Sclerosis Certified Specialist. Dr. Jackson will share her expert perspective on the clinical logistics of MS care, focusing on:Evidence-Based AssessmentTargeted InterventionPatient Education/ CoachingYou will walk away with practical, actionable knowledge. Plus, we are assembling a treatment guide for you to reference—synthesizing insights from this and our past conversations on MS—to help you provide the highest level of care.See full course details here:https://otpotential.com/ceu-podcast-courses/ot-and-multiple-sclerosis-treatmentSee all OT CEU courses here:https://otpotential.com/ceu-podcast-coursesCheck our our live webinar schedule here:https://otpotential.com/live-ot-ceu-webinarsSupport the show by using the OTPOTENTIAL Medbridge Code:https://otpotential.com/blog/promo-code-for-medbridgeTry 2 free OT Potential courses here:https://otpotential.com/free-ot-ceusSupport the show

Have you ever wondered if those expensive "stem cell" IVs are actually regenerating your body, or if they are just an overpriced, temporary anti-inflammatory boost? In this episode of Beauty Bytes, I am joined by Dr. Adeel Khan, a board-certified sports medicine physician and the CEO of Eterna Health, to expose the myths, marketing jargon, and hard truths of the regenerative medicine industry. I first heard Dr. Khan speak at the Anti-Aging World Congress in Japan, and his breakdown of what is actually happening at a cellular level completely shifted my perspective on longevity. We tackle the uncomfortable reality that the standard MSCs (Medicinal Signaling Cells) offered at most clinics aren't actually functioning as true stem cells—in fact, up to 99% of them get trapped in your lungs.

In this episode host Erin Gallardo, PT, DPT, NCS interviews Multiple Sclerosis specialist and researcher Dr. Herb Karpatkin, PT, DSc, NCS, MSCS to discuss how therapy for people with multiple sclerosis must be fundamentally different from approaches used for stroke, spinal cord injury, or TBI. In his research Herb discovered an incidental finding that led to more questions that he and his team wanted to investigate: does treadmill walking carry over to overground walking in persons with MS? In the show he explains the nuances of treadmill walking for persons with MS vs healthy controls and when to use it or not. Herb shares his framework on intermittent, high-intensity interval walking and strength training, which allow people with MS to push hard, rest, and achieve meaningful aerobic gains and functional improvements without excessive fatigue. Instead of telling people with MS they can't work hard or lift heavy, his research finds that to be absolutely untrue. Herb and Erin also discuss a couple of past patients who wanted to complete the MS Society 5k walk and what the training looked like and what could have been done differently. The topic of cooling came up and how to effectively implement this technique to allow persons with MS to do more without overheating. Check out episode 233 with Herb MS: Update on evidence based interventions to improve gait and balance 1.5 hour Mini Course  

Republican sponsors of the bill have said they'll push the Tennessee General Assembly to pass legislation that would kneecap the elected board by giving a new board of state appointees powers over MSCS.

ATS 2026 is right around the corner! Jennifer L. Taylor, MD, MSCS, ATSF –  ATS International Conference Committee chair, tenured Professor of Medicine and Pediatrics and medical director of Clinical Research Services at National Jewish Health – talks about the amazing keynote speakers for this year's conference, how to get the most out of the conference's many offerings, and a little look at how much planning goes into this influential, must-attend conference.  Early registration closes March 12! https://registration.experientevent.com/ShowATS261/Flow/ATT?atslogin=1&marketingcode=YOUTUBEATS members save even more on conference registration, so become a member or renew today: https://site.thoracic.org/membership

The Memphis-Shelby County Schools board is about to decide on the district's leadership, and candidates are campaigning for school board seats. But two sponsors of a state bill say little, if any, of that matters.

In this keynote-style episode, I break down how stem cell therapy is studied in autoimmune disease and long COVID, and how clinicians think about immune dysregulation, inflammation, and repair.I explain how stem cell therapy evolved from early bone marrow transplants and why mesenchymal stem cells (MSCs) are being explored for immune modulation rather than suppression.I also share research insights and clinical observations across autoimmune conditions, including lupus, rheumatoid arthritis, inflammatory bowel disease, and psoriasis, and discuss why outcomes can vary when working with complex biology.The second half of the episode focuses on long COVID (PASC), including common symptom patterns, proposed mechanisms, and how I evaluate whether a therapy's mechanism aligns with the underlying pathophysiology.Let's get into it._Key TakeawaysIntroduction & Opening (0:00)Autoimmune Disease Overview (1:58)Lupus (SLE) Treatment (4:43)Treatment Philosophy & Expectations (8:55)Rheumatoid Arthritis (11:32)Stages of Stem Cell Healing (15:09 )Psoriasis (17:14)Inflammatory Bowel Disease (19:55)Other Autoimmune Conditions (27:29)Long COVID (30:30)Tissue Source Comparison (46:21)Closing (49:36)Additional Resources:✨ Learn more about how to live a long and pain-free life: https://joykongmd.com/ ✨ Follow me on Facebook: https://www.facebook.com/stemcelldrjoy/ ✨ Follow me on Instagram: https://www.instagram.com/dr_joy_kong/ —Dr. Joy Kong is a regenerative medicine and anti-aging expert. Her podcast is part of her mission to reduce suffering and elevate happiness. Join us every week for the latest holistic health insights that will help you live a long and pain-free life.

“They're kind of like a hidden superhero in your body and we just didn't know they existed. Muse cells eat the damaged cells, and they can actually turn into new cells using the cellular machinery.”Dr. Adeel Khan is a global thought leader in regenerative medicine. He is the CEO and Founder of and founder of Eterna Health, whose work with MUSE cell therapy—developed in collaboration with its discoverer, Professor Mari Dezawa—has made him the go-to expert for world leaders, athletes, and celebrities Chris Hemsworth, Kim Kardashian, and Tony Robbins. In this episode, we move beyond the hype of "anti-aging" to explore the hard science of Muse cells (Multilineage-differentiating Stress-Enduring cells). Dr. Khan breaks down how these unique cells differ from the "medicinal signaling cells" (MSCs) found in most clinics and how they act as a bridge to a future where tissue regeneration is standard care.(0:00) The "Repair Guys" & The Muse Difference Dr. Khan explains why traditional stem cells (MSCs) often disappoint and how Muse cells offer the "best of both worlds": safety and pluripotency.(2:19) Smart Cells: How They Find the Damage Understanding the "homing mechanism" that allows Muse cells to sense inflammation and instinctively travel to injured areas like the brain or heart.(3:11) Curing the Incurable: Diabetes & Alzheimer's The potential of the "cure triad"—stem cells, gene therapy, and FMT—to treat complex autoimmune diseases within the next decade.(4:40) Biological Noise & The Symphony of Health How "static" in our gene expression indicates aging, and how cellular therapy can reduce this noise to restore the body's harmony.(6:40) The Viral Monkey Study Dr. Khan discusses a recent study showing significant de-aging in monkeys through high-frequency cell dosing.(7:32) Unshakeable Foundations: Lifestyle as MedicineWhy advanced therapies must be paired with purpose, community, and mindfulness to create a "bulletproof" body.(8:44) From Sketchy to StandardizedNavigating the regulatory landscape: why Muse cells are being classified as a drug in regions like the UAE and the path toward FDA approval.(12:24) A Personal MissionDr. Khan shares the origin of his journey: trying to find solutions for his mother's chronic illness when traditional medicine failed.(14:16) The Cancer HunterUnlike other pluripotent cells that risk tumor growth, Muse cells have a unique mechanism that can detect cancer cells and trigger their death.(18:30)Future Outlook: AI, Nature & Blue Zones Reflections on the risks of AI, the importance of "Blue Zone" city design, and reconnecting with nature in a post-human world.Episode Websitewww.creativeprocess.info/podInstagram:@creativeprocesspodcast

“They're kind of like a hidden superhero in your body and we just didn't know they existed. Muse cells eat the damaged cells, and they can actually turn into new cells using the cellular machinery.”Dr. Adeel Khan is a global thought leader in regenerative medicine. He is the CEO and Founder of and founder of Eterna Health, whose work with MUSE cell therapy—developed in collaboration with its discoverer, Professor Mari Dezawa—has made him the go-to expert for world leaders, athletes, and celebrities Chris Hemsworth, Kim Kardashian, and Tony Robbins. In this episode, we move beyond the hype of "anti-aging" to explore the hard science of Muse cells (Multilineage-differentiating Stress-Enduring cells). Dr. Khan breaks down how these unique cells differ from the "medicinal signaling cells" (MSCs) found in most clinics and how they act as a bridge to a future where tissue regeneration is standard care.(0:00) The "Repair Guys" & The Muse Difference Dr. Khan explains why traditional stem cells (MSCs) often disappoint and how Muse cells offer the "best of both worlds": safety and pluripotency.(2:19) Smart Cells: How They Find the Damage Understanding the "homing mechanism" that allows Muse cells to sense inflammation and instinctively travel to injured areas like the brain or heart.(3:11) Curing the Incurable: Diabetes & Alzheimer's The potential of the "cure triad"—stem cells, gene therapy, and FMT—to treat complex autoimmune diseases within the next decade.(4:40) Biological Noise & The Symphony of Health How "static" in our gene expression indicates aging, and how cellular therapy can reduce this noise to restore the body's harmony.(6:40) The Viral Monkey Study Dr. Khan discusses a recent study showing significant de-aging in monkeys through high-frequency cell dosing.(7:32) Unshakeable Foundations: Lifestyle as MedicineWhy advanced therapies must be paired with purpose, community, and mindfulness to create a "bulletproof" body.(8:44) From Sketchy to StandardizedNavigating the regulatory landscape: why Muse cells are being classified as a drug in regions like the UAE and the path toward FDA approval.(12:24) A Personal MissionDr. Khan shares the origin of his journey: trying to find solutions for his mother's chronic illness when traditional medicine failed.(14:16) The Cancer HunterUnlike other pluripotent cells that risk tumor growth, Muse cells have a unique mechanism that can detect cancer cells and trigger their death.(18:30)Future Outlook: AI, Nature & Blue Zones Reflections on the risks of AI, the importance of "Blue Zone" city design, and reconnecting with nature in a post-human world.Episode Websitewww.creativeprocess.info/podInstagram:@creativeprocesspodcast

“They're kind of like a hidden superhero in your body and we just didn't know they existed. Muse cells eat the damaged cells, and they can actually turn into new cells using the cellular machinery.”Dr. Adeel Khan is a global thought leader in regenerative medicine. He is the CEO and Founder of and founder of Eterna Health, whose work with MUSE cell therapy—developed in collaboration with its discoverer, Professor Mari Dezawa—has made him the go-to expert for world leaders, athletes, and celebrities Chris Hemsworth, Kim Kardashian, and Tony Robbins. In this episode, we move beyond the hype of "anti-aging" to explore the hard science of Muse cells (Multilineage-differentiating Stress-Enduring cells). Dr. Khan breaks down how these unique cells differ from the "medicinal signaling cells" (MSCs) found in most clinics and how they act as a bridge to a future where tissue regeneration is standard care.(0:00) The "Repair Guys" & The Muse Difference Dr. Khan explains why traditional stem cells (MSCs) often disappoint and how Muse cells offer the "best of both worlds": safety and pluripotency.(2:19) Smart Cells: How They Find the Damage Understanding the "homing mechanism" that allows Muse cells to sense inflammation and instinctively travel to injured areas like the brain or heart.(3:11) Curing the Incurable: Diabetes & Alzheimer's The potential of the "cure triad"—stem cells, gene therapy, and FMT—to treat complex autoimmune diseases within the next decade.(4:40) Biological Noise & The Symphony of Health How "static" in our gene expression indicates aging, and how cellular therapy can reduce this noise to restore the body's harmony.(6:40) The Viral Monkey Study Dr. Khan discusses a recent study showing significant de-aging in monkeys through high-frequency cell dosing.(7:32) Unshakeable Foundations: Lifestyle as MedicineWhy advanced therapies must be paired with purpose, community, and mindfulness to create a "bulletproof" body.(8:44) From Sketchy to StandardizedNavigating the regulatory landscape: why Muse cells are being classified as a drug in regions like the UAE and the path toward FDA approval.(12:24) A Personal MissionDr. Khan shares the origin of his journey: trying to find solutions for his mother's chronic illness when traditional medicine failed.(14:16) The Cancer HunterUnlike other pluripotent cells that risk tumor growth, Muse cells have a unique mechanism that can detect cancer cells and trigger their death.(18:30)Future Outlook: AI, Nature & Blue Zones Reflections on the risks of AI, the importance of "Blue Zone" city design, and reconnecting with nature in a post-human world.Episode Websitewww.creativeprocess.info/podInstagram:@creativeprocesspodcast

"The repair mechanisms don't work as well as you get older... The whole idea was: if we can give you more of the 'repair guys,' maybe we can reverse disease."Dr. Adeel Khan is a global thought leader in regenerative medicine. He is the CEO and Founder of and founder of Eterna Health, whose work with MUSE cell therapy—developed in collaboration with its discoverer, Professor Mari Dezawa—has made him the go-to expert for world leaders, athletes, and celebrities Chris Hemsworth, Kim Kardashian, and Tony Robbins. In this episode, we move beyond the hype of "anti-aging" to explore the hard science of Muse cells (Multilineage-differentiating Stress-Enduring cells). Dr. Khan breaks down how these unique cells differ from the "medicinal signaling cells" (MSCs) found in most clinics and how they act as a bridge to a future where tissue regeneration is standard care.(0:00) The Future of Regenerative Medicine(6:13) The Muse Difference: Why these cells are "pluripotent" (able to become any tissue) without the cancer risks of Yamanaka factors.(10:29) Curing the Incurable: Diabetes & Alzheimer's (11:27) The Cure Triad: How combining stem cells, gene therapy, and Fecal Microbial Transplants (FMT) could cure complex autoimmune diseases within a decade.(12:56) Biological Noise: Measuring the "mistakes" in our gene expression to quantify aging.(16:42) Lifestyle as Medicine: Why Dr. Khan prescribes community, mindfulness, and nature immersion alongside advanced therapies.(18:13) From Sketchy to Standardized: The Regulatory Landscape(23:25) A Personal Mission: Trying to Save Mom(25:38) The Cancer Hunter: How Muse cells naturally detect and trigger cell death in tumors.(29:02) Quantum Biology & Healing Frequencies(41:13) The AI Pessimist: Planning for a Post-Human World(44:03) Reconnecting with NatureEpisode Websitewww.creativeprocess.info/podInstagram:@creativeprocesspodcast

"The repair mechanisms don't work as well as you get older... The whole idea was: if we can give you more of the 'repair guys,' maybe we can reverse disease."Dr. Adeel Khan is a global thought leader in regenerative medicine. He is the CEO and Founder of and founder of Eterna Health, whose work with MUSE cell therapy—developed in collaboration with its discoverer, Professor Mari Dezawa—has made him the go-to expert for world leaders, athletes, and celebrities Chris Hemsworth, Kim Kardashian, and Tony Robbins. In this episode, we move beyond the hype of "anti-aging" to explore the hard science of Muse cells (Multilineage-differentiating Stress-Enduring cells). Dr. Khan breaks down how these unique cells differ from the "medicinal signaling cells" (MSCs) found in most clinics and how they act as a bridge to a future where tissue regeneration is standard care.(0:00) The Future of Regenerative Medicine(6:13) The Muse Difference: Why these cells are "pluripotent" (able to become any tissue) without the cancer risks of Yamanaka factors.(10:29) Curing the Incurable: Diabetes & Alzheimer's (11:27) The Cure Triad: How combining stem cells, gene therapy, and Fecal Microbial Transplants (FMT) could cure complex autoimmune diseases within a decade.(12:56) Biological Noise: Measuring the "mistakes" in our gene expression to quantify aging.(16:42) Lifestyle as Medicine: Why Dr. Khan prescribes community, mindfulness, and nature immersion alongside advanced therapies.(18:13) From Sketchy to Standardized: The Regulatory Landscape(23:25) A Personal Mission: Trying to Save Mom(25:38) The Cancer Hunter: How Muse cells naturally detect and trigger cell death in tumors.(29:02) Quantum Biology & Healing Frequencies(41:13) The AI Pessimist: Planning for a Post-Human World(44:03) Reconnecting with NatureEpisode Websitewww.creativeprocess.info/podInstagram:@creativeprocesspodcast

https://www.lydianclinic.com/blog/stem-cell-therapy-cost-back-pain-korea-2025/Experts confirm stem cell therapy effectively treats chronic back pain by regenerating damaged tissue, not just masking symptoms. Discover how MSCs work, what to expect, and why this minimally invasive option is gaining global attention for lasting relief. Lydian Cosmetic Surgery Clinic City: Seoul Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam Website: https://www.lydianclinic.com/

I presented this lecture to help medical providers see just how much data we actually have when it comes to stem cell therapy. If we never look at the studies, we assume they don't exist, but they do. And they're not just encouraging but very inspiring.As the founder of the American Academy of Integrative Cell Therapy, I've spent years digging into peer-reviewed research and applying it in real clinical settings. In this talk, I walk through compelling studies that show how mesenchymal stem cells (MSCs) are being used to treat autoimmune diseases, neurological disorders, cardiovascular conditions, and even things like erectile dysfunction and autism.I look at the regenerative power of MSCs, how they travel where they're needed, and the wide-ranging ways they modulate inflammation, restore function, and enhance healing.Stem cell research is moving fast, and we're witnessing the early days of a major shift in modern medicine.

Susan Matulevicius, MD, MSCS, a national expert on resilience and work-life integration, joins the Faculty Factory Podcast this week for a discussion to help us better deal with life's inevitable stumbling blocks. Dr. Matulevicius serves as Associate Dean of Faculty Wellness and is a Professor of Internal Medicine, Cardiology, at the UT Southwestern Medical Center in Dallas. To help us think about how to create professional well-being in academic medicine, she discusses the 5 Ps: Person Purpose Path Prioritization Permission “When you get down to it, our values generally align with our purpose, and it helps us refocus when we encounter those little stumbling blocks that life puts in our way,” she said. She also touches on the value of understanding your purpose in relation to Self-Determination Theory, which is an important paradigm related to this conversation. With reassurance, Dr. Matulevicius warmly reminds us midway through the conversation of something we all need to hear occasionally: “Sometimes it's okay to not be okay." “Life and work are not always predictable, and sometimes your emotions aren't predictable in the moment. It's okay to recognize that you need more support to help you through that moment,” she said.  Learn More: https://facultyfactory.org/Susan-Matulevicius

In this episode, I'm explaining what I believe is the most powerful tool we've ever had to slow and reverse the aging process.  We'll dive into the science behind why your body loses its regenerative fire as you age and how mesenchymal stem cells (MSCs), especially from young birth tissue, can reignite that healing intelligence from within.I've seen firsthand how inflammation silently drives disease and aging. Young mesenchymal stem cells have the ability to calm that Inflammaging fire and reawaken our body's natural healing systems.Let's talk about what's possible when we tap into the original code of life.Key TakeawaysIntroduction (00:00)Stem cell therapy and DNA intelligence (01:03)Inflammation and aging (07:07)Mechanisms of stem cell function (10:09)Comparison of young and old MSCs (21:56)Anti-aging benefits of stem cell therapy (31:34)Human studies and frailty (39:09)Anti-aging protocol and safety (41:57)Additional Resources:✨ Learn more about how to live a long and pain-free life: https://joykongmd.com/ ✨ Follow me on Facebook: https://www.facebook.com/stemcelldrjoy/ ✨ Follow me on Instagram: https://www.instagram.com/dr_joy_kong/ —Dr. Joy Kong is a regenerative medicine and anti-aging expert. Her podcast is part of her mission to reduce suffering and elevate happiness. Join us every week for the latest holistic health insights that will help you live a long and pain-free life.

In this episode of the Ageless Future Podcast, Cade Archibald dives into the powerful world of regenerative medicine, exploring how stem cells—especially those derived from umbilical cord tissue—enhance vitality, reduce inflammation, and support long-term tissue repair. He explains how mesenchymal stem cells (MSCs) stimulate healing through anti-inflammatory cytokines, improve mitochondrial performance, and even impact brain health through intranasal delivery. Cade also shares clinical outcomes and real-world results, including joint regeneration, pain reduction, and improved mobility. Wrapping up, he challenges listeners to take a break from alcohol to support their own stem cell health and longevity goals during the holidays.LIKE/FOLLOW/SUBSCRIBE AGELESS FUTURE:YouTube -https://www.youtube.com/@ReganArchibald / https://www.youtube.com/@Ageless.FutureLinkedIn: https://www.linkedin.com/in/regan-archibald-ab70b813Instagram: https://www.instagram.com/ageless.future/Facebook: https://www.facebook.com/AgelessFutureHealth/

Dr. Jeff Graham talks with Dr. Mattias Bernow, a physician, economist, and CEO of Cellcolabs — about the current state of stem cell therapy. They discuss how mesenchymal stem cells (MSCs) function through signaling rather than cell replacement, where evidence supports their use today, and why good manufacturing practices (GMP) are essential for safety and efficacy. The conversation explores clinical data on cardiovascular, autoimmune, and neurodegenerative diseases, and what large-scale, evidence-based production could mean for the future of regenerative medicine.

Stem cell therapy is at the forefront of providing groundbreaking treatments for conditions ranging from joint pain to autoimmune disorders.However, with its vast potential, it also raises important ethical questions, especially around sourcing and regulation.In this episode, Dr. Joy Kong breaks down the ethical considerations in stem cell therapy. She explains how stem cells are sourced ethically, specifically from umbilical cords, and dispels common misconceptions around the ethics of using stem cells for treatment.She describes how the process works, including the rigorous screening protocols for both donors and tissue collection.Dr. Kong also shares her thoughts on the controversial use of embryonic stem cells and contrasts that with the use of mesenchymal stem cells (MSCs) that are derived from umbilical cords.Unlike embryonic stem cells, umbilical-derived MSCs do not involve ethical dilemmas as they come from healthy, living births, and the collection process is entirely voluntary, with strict guidelines in place to avoid exploitation.If you've ever questioned the ethics behind stem cell treatments or want to understand the reality of stem cell sourcing and use, this episode is a must-listen.Key TakeawaysIntroduction (00:00)Historical context of stem cells (00:52)Types of stem cells and their functions (03:49)Safety and efficacy of stem cell therapy (06:51)Ethical considerations and stem cell sources (07:38)Case studies and practical applications (17:44)Combining stem cell therapy with light therapy (30:23)Holistic approach to stem cell therapy (35:07)Challenges and successes in stem cell treatment (37:36)Final thoughts (43:04)Additional Resources:✨ Learn more about how to live a long and pain-free life: https://joykongmd.com/ ✨ Follow me on Facebook: https://www.facebook.com/stemcelldrjoy/ ✨ Follow me on Instagram: https://www.instagram.com/dr_joy_kong/ —Dr. Joy Kong is a regenerative medicine and anti-aging expert. Her podcast is part of her mission to reduce suffering and elevate happiness. Join us every week for the latest holistic health insights that will help you live a long and pain-free life.

Luke Cymbal and Kristen New are filling in for Todd Starnes this week, while Todd speaks at a the Spiritual Leadership Conference in Los Angeles! Live Weekdays 7AM Central on the KWAM app, or Mighty990.comSee omnystudio.com/listener for privacy information.

Today, I'm sitting down with the brilliant Dr. Joy Kong, a trailblazing clinician and scientist at the forefront of regenerative medicine and stem cell therapy. In this episode, Dr. Kong shares how she blends rigorous science with hands-on clinical practice to help people tackle everything from brain injuries and autoimmune conditions to skin aging and joint pain—often with transformative results.   Products she mentions: CharaOmni facial cream   Episode Timestamps: How stem cells address chronic illness ... 00:07:12 When to use IV vs. local stem cells ... 00:10:06 Types and sources: autologous, umbilical, MSCs ... 00:11:40 Why younger stem cells are superior ... 00:17:38 Emerging cell therapies: V-cells, Muse cells ... 00:20:25 Decline of stem cells with age ... 00:24:19 Stem cell therapy for neurological, organ, and autoimmune conditions ... 00:27:14 Techniques to target brain and optimize therapy ... 00:29:46 Donor screening and safety ... 00:34:41 Stem cells in healing injuries and recovery ... 00:42:28 Immune modulation and overall rejuvenation ... 00:44:56 Anti-aging protocols: frequency of IV therapy ... 00:48:36 Aesthetic uses: skin, microneedling, hair ... 00:50:08 Handling and potency of exosomes ... 00:55:01 Future of anti-aging and stem cell therapy ... 00:59:02 Legality and access in the US ... 01:03:13   Our Amazing Sponsors: Wizard Sciences - NMN+G Rx: A scientifically formulated blend of NMN, ginsenosides from Panax ginseng, and apigenin. Together, they enhance mitochondrial function, boost NAD+ levels, and support cellular repair. Go to wizardsciences.com and look for NMN+G. Use code NAT15 at checkout to get 15% off your purchase.   Ultimate GI Repair by LVLUP Health - Whether you're struggling with digestive discomfort or want to strengthen your gut health, Ultimate GI Repair provides the comprehensive support your body needs to restore balance. The ingredients are unmatched! Visit https://lvluphealth.com/ and use code NAT at checkout for 20 % off.   Body Cream by Young Goose - Powered by NAD+ APEX, CelVio Spermidine, and targeted peptides, this advanced formula restores cellular energy, supports collagen production, and enhances skin resilience. It clears cellular waste, improves skin texture, and deeply hydrates areas where aging shows most—like arms, legs, neck, and décolleté. Visit YoungGoose.com—use code NAT10 to get started, or 5NAT if you're an existing customer.   Nat's Links:  YouTube Channel Join My Membership Community Sign up for My Newsletter  Instagram  Facebook Group

Today we have Dr. Mari Dezawa, one of the world's leaders in stem-cell research and regenerative medicine. Mari is a pioneer in this emerging field and is known worldwide for her discovery of MUSE cells, a unique type of stem cell with exciting clinical potential. MUSE is short for Multilineage-Differentiating Stress-Enduring Cells. The discovery of the MUSE cell in humans has many biological and medical implications, and the human body may have a greater regenerative potential than we might have ever imagined. In collaboration with major national and international institutions, Mari and her colleagues are promoting research on MUSE cell-based regenerative medicine for diseases without definitive treatments. She and her team are also exploring the differences in regenerative capacity between less and more complex animals from the viewpoint of the stem-cell system. Mari is a professor and chair of the Division of Stem Cell Biology and Histology at Tohoku University School of Medicine. She has published more than 200 papers and is particularly known for her 2010 paper on the mechanisms of MUSE cells. In 2018, she was appointed a fellow of the U.S. National Academy of Inventors and has been the recipient of numerous awards, including the Japanese Government's Prize for the Commendation for Science and Technology. Show notes: [00:04:10] Ken opens the interview by mentioning that although Mari was born in Japan, her family moved to the U.S. when she was only eight months old. Ken asks if it is true that Mari finds it difficult to answer the question of where her hometown is. [00:05:23] Ken asks Mari how she handled moving so much as a child. [00:05:52] Ken mentions that Mari's father was a researcher and asks when she became passionate about research and science. [00:06:58] Ken mentions that Mari attended the Chiba University School of Medicine and asks what inspired her to go to medical school. [00:07:19] Ken explains that after Mari earned her medical degree, she attended Chiba University Graduate School of Medicine for her Ph.D. Ken mentions that while Mari was initially a cardiology resident, she later decided to focus on clinical research and became a stem-cell researcher. Ken asks what led her to shift from cardiology to stem-cell research. [00:08:25] Ken explains that Mari is well-known for her research into the role of stem cells in regeneration and functional recovery of nerve and muscle cells. Ken asks how and when she first became interested in stem cells. [00:09:56] Ken asks Mari to give a brief overview of stem cells and their significance. [00:11:18] Ken mentions that Mari remained at Chiba University as a research associate after earning her Ph.D in 1995. She then took a position as an associate professor at Yokohama City University Graduate School of Medicine before accepting a position at Kyoto University Graduate School of Medicine as an associate professor in 2003. Ken explains that while at Kyoto, Mari developed methods to induce bone marrow stromal cells to generate neuro and skeletal muscle cells, which play a crucial role in tissue repair and regeneration and are widely studied for their potential to serve as therapeutic agents. Ken asks Mari to give a quick primer on the crucial role these cells play in tissue repair. [00:13:25] Ken explains that in 2003, a member of Mari's technical staff at Kyoto asked her whether they should discard some cultured adult rat and human bone marrow mesenchymal stem cells (MSCs) after she had noticed several strange cell clusters. Ken asks Mari to share what happened next and how this set her on the path to the discovery of Multilineage-Differentiating Stress-Enduring Cells. [00:16:03] Ken asks Mari to elaborate on this story and explain how a mistake led to this incredible discovery. [00:20:48] Ken explains that in 2008 Mari became professor and chair of the Department of Stem Cell Biology and Histology at Tohoku University Graduat...